Avid Bioservices

Avid Bioservices, Inc. engages in the commercial manufacturing. The firm focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

TUSTIN, Calif., Dec.  04, 2019  (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E Convertible Preferred Stock (the "Series E Preferred Stock").

Avid Bioservices - Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices (CDMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avid Bioservices (CDMO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Senior Executive with More than 25 Years of Biopharmaceutical Industry Manufacturing Operations Experience Senior Executive with More than 25 Years of Biopharmaceutical Industry Manufacturing Operations Experience

Avid Bioservices Names Richard Richieri as Chief Operations Officer

Company to Host Open House to Celebrate Official Launch of Newly Expanded Laboratories Company to Host Open House to Celebrate Official Launch of Newly Expanded Laboratories

Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure

Avid Bioservices, Inc. (CDMO) CEO Rick Hancock on Q1 2020 Results - Earnings Call Transcript

Investors and traders alike always seem to be on the hunt for the next big biotech breakout story.

Why Avid Bioservices Stock Could Still Double, Maybe

Shares are jumping in response to upbeat earnings. Here are the must-know details for investors.

Why Avid Bioservices Is Soaring Today

CDMO earnings call for the period ending January 31, 2019.

News for Avid Bioservices Stock (CDMOP)